Paul F. Truex
2013
In 2013, Paul F. Truex earned a total compensation of $3.2M as President, CEO and Director at Anthera Pharmaceuticals, a 233% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $62,315 |
|---|---|
| Option Awards | $2,500,605 |
| Salary | $515,000 |
| Stock Awards | $86,815 |
| Total | $3,164,735 |
Truex received $2.5M in option awards, accounting for 79% of the total pay in 2013.
Truex also received $62.3K in non-equity incentive plan, $515K in salary and $86.8K in stock awards.
Rankings
In 2013, Paul F. Truex's compensation ranked 2,385th out of 12,286 executives tracked by ExecPay. In other words, Truex earned more than 80.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,385 out of 12,286 | 81st |
Division Manufacturing | 795 out of 4,612 | 83rd |
Major group Chemicals And Allied Products | 215 out of 1,466 | 85th |
Industry group Drugs | 143 out of 1,160 | 88th |
Industry Pharmaceutical Preparations | 121 out of 890 | 86th |
Source: SEC filing on April 9, 2015.
Truex's colleagues
We found four more compensation records of executives who worked with Paul F. Truex at Anthera Pharmaceuticals in 2013.